{"id":"https://openalex.org/W32050558","doi":null,"title":"[Management of the cardiology patient with polyvascular disease: PRISMA study].","display_name":"[Management of the cardiology patient with polyvascular disease: PRISMA study].","publication_year":2004,"publication_date":"2004-09-01","ids":{"openalex":"https://openalex.org/W32050558","mag":"32050558","pmid":"https://pubmed.ncbi.nlm.nih.gov/15521475"},"language":"fr","primary_location":{"id":"pmid:15521475","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15521475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives des maladies du coeur et des vaisseaux","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019066932","display_name":"Maxime Cournot","orcid":"https://orcid.org/0000-0001-6145-7483","observed_orcids":["https://orcid.org/0000-0001-6145-7483"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M Cournot","raw_affiliation_strings":["INSERM U5558, D\u00e9partement d'\u00e9pid\u00e9miologie, Facult\u00e9 de m\u00e9decine, Toulouse"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM U5558, D\u00e9partement d'\u00e9pid\u00e9miologie, Facult\u00e9 de m\u00e9decine, Toulouse","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012628875","display_name":"Jean\u2010Pierre Cambou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J P Cambou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017946579","display_name":"Jean Ferri\u00e8res","orcid":"https://orcid.org/0000-0001-6144-1297","observed_orcids":["https://orcid.org/0000-0001-6144-1297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Ferri\u00e8res","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052667302","display_name":"Olivier Grenier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Grenier","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111548114","display_name":"M.A. Herrmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M A Herrmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108432941","display_name":"Christelle Cantet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C Cantet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111631388","display_name":"Alain Leizorovicz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Leizorovicz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2072,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.59580198,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"97","issue":"9","first_page":"841","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6845999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6845999956130981,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10926","display_name":"Peripheral Artery Disease Management","score":0.06300000101327896,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.05420000106096268,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polyvascular-disease","display_name":"polyvascular disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/atherothrombosis","display_name":"atherothrombosis","score":0.9890000224113464},{"id":"https://openalex.org/keywords/myocardial-infarction","display_name":"myocardial infarction","score":0.9610000252723694},{"id":"https://openalex.org/keywords/peripheral-vascular-disease","display_name":"peripheral vascular disease","score":0.9190000295639038},{"id":"https://openalex.org/keywords/ischemic-stroke","display_name":"ischemic stroke","score":0.8450000286102295},{"id":"https://openalex.org/keywords/secondary-prevention","display_name":"secondary prevention","score":0.9319999814033508},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.8560000061988831},{"id":"https://openalex.org/keywords/lipid-management","display_name":"lipid control","score":0.6690000295639038},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.6159999966621399},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.9330000281333923},{"id":"https://openalex.org/keywords/antiplatelet-therapy","display_name":"antiplatelet therapy","score":0.9139999747276306},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5120000243186951},{"id":"https://openalex.org/keywords/risk-factor-management","display_name":"risk factor control","score":0.5709999799728394}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9176856279373169},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.8581659197807312},{"id":"https://openalex.org/C3018906752","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary heart disease","level":2,"score":0.5593053102493286},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06605106592178345}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000925","descriptor_name":"Anticoagulants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002545","descriptor_name":"Brain Ischemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003920","descriptor_name":"Diabetes Mellitus","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006949","descriptor_name":"Hyperlipidemias","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D009203","descriptor_name":"Myocardial Infarction","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010818","descriptor_name":"Practice Patterns, Physicians'","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D010975","descriptor_name":"Platelet Aggregation Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D013927","descriptor_name":"Thrombosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D016491","descriptor_name":"Peripheral Vascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020521","descriptor_name":"Stroke","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:15521475","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15521475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Archives des maladies du coeur et des vaisseaux","raw_type":"English Abstract"},{"id":"mag:32050558","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15521475","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2369758987","https://openalex.org/W4403807844","https://openalex.org/W2970767021","https://openalex.org/W4253918117","https://openalex.org/W4389376732","https://openalex.org/W1968634036","https://openalex.org/W4248407368","https://openalex.org/W3107568360","https://openalex.org/W2169002626","https://openalex.org/W3025372664"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Myocardial":[1],"infarction":[2],"(MI),":[3],"peripheral":[4,209],"vascular":[5,10,133,210],"disease":[6,97,183,211],"and":[7,21,27,41,68,89,115,129,308],"ischaemic":[8],"cerebral":[9],"accident":[11],"(CVA)":[12],"are":[13],"three":[14],"manifestations":[15,139,250],"of":[16,32,45,112,126,131,164,181,185,208,217,224,231,237,247,256,268,272,286,293],"the":[17,24,38,42,55,72,77,95,110,113,120,127,132,151,162,170,179,206,222,269,283,291,311],"same":[18,25],"disease,":[19],"atherothrombosis,":[20],"they":[22,155],"share":[23],"pathophysiology":[26],"prognosis.":[28],"OBJECTIVE:":[29],"The":[30,65,245],"aim":[31],"this":[33],"work":[34],"was":[35,98,146,174,212,226,251],"to":[36,93,282,299],"describe":[37],"clinical":[39,66],"characteristics":[40,67],"medical":[43,69],"management":[44,70,271],"polyvascular":[46,182,192,239,273],"patients":[47,75,106,123,136,153,194,199,240],"in":[48,58,84,119,150,161,178,191,197,259,309],"cardiology.":[49],"METHOD:":[50],"Cardiologists":[51],"from":[52],"all":[53],"over":[54],"country":[56],"participated":[57],"a":[59,85],"consultation":[60],"register":[61,78,114,128],"for":[62,71,79,275],"3":[63,74],"weeks.":[64],"first":[73],"on":[76],"each":[80],"cardiologist":[81],"were":[82,107,117,140],"studied":[83],"national":[86],"multicentre":[87],"study":[88],"then":[90],"compared":[91],"according":[92],"whether":[94],"atherothrombotic":[96,249],"isolated":[99,166,201],"or":[100,188],"polyvascular.":[101],"RESULTS:":[102],"In":[103,203],"total,":[104],"100,429":[105],"examined":[108],"during":[109],"period":[111],"2,780":[116],"included":[118],"study.":[121],"Polyvascular":[122],"represented":[124],"7%":[125],"22%":[130],"patients.":[134,261],"These":[135,263],"with":[137,200,214,228,253],"multiple":[138,248],"frequently":[141],"diabetics.":[142],"A":[143],"lipid":[144],"profile":[145],"available":[147],"less":[148,175,215,229],"often":[149,176],"cardiac":[152,193,198,204,260],"when":[154],"had":[156],"another":[157],"disorder":[158,167],"(72.4%)":[159],"than":[160],"case":[163,180],"an":[165],"(78.9%).":[168],"Whatever":[169],"initial":[171],"disorder,":[172],"dyslipidaemia":[173],"controlled":[177],"(63%":[184],"LDL-C":[186],">":[187],"=":[189],"1.3g/l":[190],"vs":[195],"52%":[196],"disease).":[202],"patients,":[205,274],"presence":[207,223,246],"associated":[213,227,252],"prescription":[216,230,255],"beta":[218],"blockers":[219],"(OR=0.4":[220],"[0.3-0.6]),":[221],"CVA":[225],"statins":[232],"(OR=0.7":[233],"[0.5-0.9]).":[234],"Eight":[235],"out":[236],"10":[238],"received":[241],"anti-platelet":[242],"aggregation":[243],"treatment.":[244],"greater":[254],"ACEI,":[257],"except":[258],"CONCLUSION:":[262],"results":[264],"improve":[265],"our":[266],"understanding":[267],"specific":[270],"whom":[276],"secondary":[277],"prevention":[278],"is":[279],"paramount":[280],"due":[281],"higher":[284],"risk":[285,306],"recurrence.":[287],"They":[288],"should":[289],"prompt":[290],"reinforcement":[292],"measures":[294],"which":[295],"have":[296],"been":[297],"shown":[298],"be":[300],"effective,":[301],"such":[302],"as":[303],"managing":[304],"major":[305],"factors,":[307],"particular":[310],"dislipidaemias.":[312]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2016-06-24T00:00:00"}